CD34 and breast cancer: More importantly, BC induced the hyperphosphorylation of FLT3 and cKIT in mouse primary BMMNCs and human CD34+ UCB cells in vitro, indicating the inhibition of BC on cellular STS1 and STS2 in primary HSPCs.